Canadian Forces Health Services Group Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02667730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now